Skip to main content

Table 3 Maximum toxicity per patient

From: Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer

Toxicity

Cohort 1 (n = 5)

Cohort 2 (n = 4)

Cohort 3 (n = 3)

All cohort (n = 12)

Grade

Grade

Grade

Grade

1–2

3

1–2

3

1–2

3

1–2

3

Hematological

 Neutropenia

0

0

1

0

0

1

1

1

 Lymphopenia

3

1

3

0

0

0

6

1

 Anemia

3

1

3

1

2

0

8

2

 Thrombocytopenia

2

1

1

0

0

0

3

1

 Elevated AST

2

0

1

0

0

0

3

0

 Elevated ALT

0

0

1

0

0

0

1

0

 Elevated total billirubin

0

1

2

0

1

0

3

1

Non-hematological

 Fatigue

2

0

3

0

3

0

8

0

 Fever

1

0

0

0

0

0

1

0

 Anorexia

0

1

0

1

0

0

0

2

 Nausea

0

0

0

0

2

0

2

0

 Diarrhea

0

0

2

0

0

0

2

0

 Constipation

1

0

2

0

0

0

3

0